Jaktinib Hydrochloride Tablets in Intermediate-risk and High-risk Myelofibrosis.
Clinical trial NCT03886415 · COMPLETED
Trial details
- NCT number
- NCT03886415
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-08
- Primary completion
- 2021-02-02
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.